| pubmed-article:14667587 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14667587 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:14667587 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
| pubmed-article:14667587 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:14667587 | lifeskim:mentions | umls-concept:C0456599 | lld:lifeskim |
| pubmed-article:14667587 | lifeskim:mentions | umls-concept:C0805586 | lld:lifeskim |
| pubmed-article:14667587 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:14667587 | lifeskim:mentions | umls-concept:C0449445 | lld:lifeskim |
| pubmed-article:14667587 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:14667587 | pubmed:dateCreated | 2003-12-11 | lld:pubmed |
| pubmed-article:14667587 | pubmed:abstractText | Stage IIIb (T4/N3) non-small-cell lung cancer (NSCLC) is considered an inoperable disease and treatment is an enduring challenge. Surgery after induction therapy seems to improve locoregional control. We report the results of a phase II prospective trimodality trial (chemotherapy and concomitant radiotherapy plus surgery) in patients with stage IIIb NSCLC. | lld:pubmed |
| pubmed-article:14667587 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14667587 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14667587 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:14667587 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14667587 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14667587 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14667587 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:14667587 | pubmed:issn | 0003-4975 | lld:pubmed |
| pubmed-article:14667587 | pubmed:author | pubmed-author:TrodellaLucio... | lld:pubmed |
| pubmed-article:14667587 | pubmed:author | pubmed-author:GranonePierlu... | lld:pubmed |
| pubmed-article:14667587 | pubmed:author | pubmed-author:MacisGiuseppe... | lld:pubmed |
| pubmed-article:14667587 | pubmed:author | pubmed-author:MargaritoraSt... | lld:pubmed |
| pubmed-article:14667587 | pubmed:author | pubmed-author:CesarioAlfred... | lld:pubmed |
| pubmed-article:14667587 | pubmed:author | pubmed-author:D'AngelilloRo... | lld:pubmed |
| pubmed-article:14667587 | pubmed:author | pubmed-author:GalettaDomeni... | lld:pubmed |
| pubmed-article:14667587 | pubmed:author | pubmed-author:PorziellaVena... | lld:pubmed |
| pubmed-article:14667587 | pubmed:author | pubmed-author:SterziSilviaS | lld:pubmed |
| pubmed-article:14667587 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14667587 | pubmed:volume | 76 | lld:pubmed |
| pubmed-article:14667587 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14667587 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14667587 | pubmed:pagination | 1802-8; discussion 1808-9 | lld:pubmed |
| pubmed-article:14667587 | pubmed:dateRevised | 2006-4-24 | lld:pubmed |
| pubmed-article:14667587 | pubmed:meshHeading | pubmed-meshheading:14667587... | lld:pubmed |
| pubmed-article:14667587 | pubmed:meshHeading | pubmed-meshheading:14667587... | lld:pubmed |
| pubmed-article:14667587 | pubmed:meshHeading | pubmed-meshheading:14667587... | lld:pubmed |
| pubmed-article:14667587 | pubmed:meshHeading | pubmed-meshheading:14667587... | lld:pubmed |
| pubmed-article:14667587 | pubmed:meshHeading | pubmed-meshheading:14667587... | lld:pubmed |
| pubmed-article:14667587 | pubmed:meshHeading | pubmed-meshheading:14667587... | lld:pubmed |
| pubmed-article:14667587 | pubmed:meshHeading | pubmed-meshheading:14667587... | lld:pubmed |
| pubmed-article:14667587 | pubmed:meshHeading | pubmed-meshheading:14667587... | lld:pubmed |
| pubmed-article:14667587 | pubmed:meshHeading | pubmed-meshheading:14667587... | lld:pubmed |
| pubmed-article:14667587 | pubmed:meshHeading | pubmed-meshheading:14667587... | lld:pubmed |
| pubmed-article:14667587 | pubmed:meshHeading | pubmed-meshheading:14667587... | lld:pubmed |
| pubmed-article:14667587 | pubmed:meshHeading | pubmed-meshheading:14667587... | lld:pubmed |
| pubmed-article:14667587 | pubmed:meshHeading | pubmed-meshheading:14667587... | lld:pubmed |
| pubmed-article:14667587 | pubmed:meshHeading | pubmed-meshheading:14667587... | lld:pubmed |
| pubmed-article:14667587 | pubmed:meshHeading | pubmed-meshheading:14667587... | lld:pubmed |
| pubmed-article:14667587 | pubmed:meshHeading | pubmed-meshheading:14667587... | lld:pubmed |
| pubmed-article:14667587 | pubmed:meshHeading | pubmed-meshheading:14667587... | lld:pubmed |
| pubmed-article:14667587 | pubmed:meshHeading | pubmed-meshheading:14667587... | lld:pubmed |
| pubmed-article:14667587 | pubmed:meshHeading | pubmed-meshheading:14667587... | lld:pubmed |
| pubmed-article:14667587 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:14667587 | pubmed:articleTitle | Enduring challenge in the treatment of nonsmall cell lung cancer with clinical stage IIIB: results of a trimodality approach. | lld:pubmed |
| pubmed-article:14667587 | pubmed:affiliation | Department of Surgical Sciences, Catholic University, Rome, Italy. mimgaleta@yahoo.com | lld:pubmed |
| pubmed-article:14667587 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14667587 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:14667587 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
